Back to Search
PATRICK YUE, M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1720184310Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
A79816(CA)
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
A79816(CA)
Clinical Trials (2)
2
Linked Trials
0
Recruiting
2
With Results
Research & Publications (20)
Comparison of the Seattle Angina Questionnaire With Daily Angina Diary in the TERISA Clinical Trial.
PMID 25249560·Circ Cardiovasc Qual Outcomes·2014
4-observational
Decreased red blood cell use and mortality in hospitalized patients.
PMID 24978650·JAMA Intern Med·2014
4-observational
Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina).
PMID 23500237·J Am Coll Cardiol·2013
2-rct
Targeting STAT3 in cancer: how successful are we?
PMID 19053881·Expert Opin Investig Drugs·2009
6-review
Preparation, characterization, and bioavailability of ursodeoxycholic acid-phospholipid complex in vivo.
PMID 18612911·Drug Dev Ind Pharm·2008
4-observational
Process optimization, characterization and pharmacokinetic evaluation in rats of ursodeoxycholic acid-phospholipid complex.
PMID 18446498·AAPS PharmSciTech·2008
7-preclinical
The study to reduce the hemolysis side effect of puerarin by a submicron emulsion delivery system.
PMID 18175940·Biol Pharm Bull·2008
7-preclinical
Development and optimization of intravenous puerarin emulsions formation by a novel complex-phase inversion-homogenization technology.
PMID 17978512·Chem Pharm Bull (Tokyo)·2007
8-other
[Preparation and characterization of the puerarin submicron emulsion].
PMID 17702404·Yao Xue Xue Bao·2007
8-other
Determination of Huperzine A in rat plasma by high-performance liquid chromatography with a fluorescence detector.
PMID 17408901·J Pharm Biomed Anal·2007
7-preclinical
Huperzine A in rat plasma and CSF following intranasal administration.
PMID 17241758·Int J Pharm·2007
4-observational
Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse.
PMID 17122193·Am J Physiol Heart Circ Physiol·2007
7-preclinical
[Advances in the study of cardiac M3 receptor as a novel target of antiarrhythmic drugs].
PMID 17039772·Yao Xue Xue Bao·2006
6-review
The angiosuppressive effects of 20(R)- ginsenoside Rg3.
PMID 16793023·Biochem Pharmacol·2006
7-preclinical
Depletion of intracellular glutathione contributes to JNK-mediated death receptor 5 upregulation and apoptosis induction by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me).
PMID 16582599·Cancer Biol Ther·2006
8-other
Ischemia impairs the association between connexin 43 and M3 subtype of acetylcholine muscarinic receptor (M3-mAChR) in ventricular myocytes.
PMID 16543729·Cell Physiol Biochem·2006
4-observational
Elucidation of the mechanisms underlying the angiogenic effects of ginsenoside Rg(1) in vivo and in vitro.
PMID 16328162·Angiogenesis·2005
4-observational
Interfacial forces and Marangoni flow on a nematic drop retracting in an isotropic fluid.
PMID 16122548·J Colloid Interface Sci·2005
8-other
[Efficient expression of exogenous human gp96 gene in tumor cells].
PMID 12479062·Ai Zheng·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3801 MIRANDA AVE
PALO ALTO, CA 94304 - Phone
- (650) 723-8222
Quick Facts
- NPI
- 1720184310
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile